Brand new UK startup RQ Biotechnology has been thrust into the spotlight after signing a $157 million licensing The post AstraZeneca buys into startup...
Enzolytics Inc (OTCMKTS: ENZC) is making a powerful move up the charts in recent days since reversing off $0.06 support levels, the second time it has...
A comparison of four COVID-19 vaccinations shows that messenger RNA (mRNA) vaccines — Pfizer-BioNTech and Moderna — perform better against the World...
Last week I invited 4 deeply experienced biopharma execs to gather for an hour to discuss what they’ve learned over the years about developing drugs....
As new drug modalities and delivery systems continue to evolve, fresh challenges arise, especially for bioprocessing. Here at GEN, we’ve spoken with...
AstraZeneca topped off a very busy week with the company's first-quarter 2022 financial report, citing a total of $11.39 billion in revenue, a whopping...
Enzolytics Inc (OTCMKTS: ENZC) is making an explosive move up the charts after the Company announced a progress update and more on its future plans. The...
Enzolytics Inc (OTCMKTS: ENZC) is easily one of the most exciting stocks currently trading on the OTCQB; trading 3 tenths of a penny over 52-week lows...
The U.S. Food and Drug Administration extended by three months the regulator agency's review of Regeneron Pharmaceuticals Inc.'s application for full approval...
Antibody-drug conjugates (ADCs) have been in development for decades, but only about a dozen have received FDA approval. Approximately 50 biopharma companies...
The New England Journal of Medicine (NEJM) today published final results of a nationwide multicenter study led by researchers at Johns Hopkins Medicine...
Evusheld is an antibody drug from AstraZeneca intended to help prevent COVID-19 infection for immunocompromised and other vulnerable patients.
With the emergence of the new but not necessarily more dangerous Omicron subvariant BA.2, the FDA on Friday announced that GlaxoSmithKline and Vir’s...
Watch: Rand Paul Declares Fauci "A Menace" To Society Authored by Steve Watson via Summit News, Senator Rand Paul declared Wednesday that...
When Longxing Cao arrived as a postdoc at the University of Washington in 2017, David Baker’s lab was already known as the leader in a niche...
Fighting hidden coronavirus variants is like a whack-a-mole game and this company wants to try a new approach.
URBANA, Ill. – Scientists at the University of Illinois at Urbana-Champaign and Mie University in Japan have developed monoclonal antibodies that prevent...
Year three of the Covid-19 pandemic just began, but this far in, Omega Funds thinks it’s not too late to launch a biotech to fight SARS-CoV-2...
The U.S. government will run out of supplies of COVID-19 treatments known as monoclonal antibodies as soon as late May and will have to scale back...
Although treatments for Ebola have helped many people overcome this deadly disease, the virus can persist in the brain and cause a lethal relapse.
Close interactions with infectious disease set both University of California, Santa Cruz graduate student Ana Nuñez Castrejon and Associate Professor...
The World Health Organization (WHO) announced the opening of a global biomanufacturing hub located in South Korea to The post WHO announces international...
On the heels of investing roughly $214 million last week to CEPI’s pandemic preparedness plan, the UK is pivoting — and using $345 million to bolster...
President Joe Biden is not backing down on advocating for Medicare to negotiate drug prices. In his first State of the Union on Tuesday evening, which...
The varying impurity profiles of mRNA from the IVT step calls on options in purification technologies that would allow process development scientists to...
The BA.2 subvariant of Omicron, which appears to be even more transmissible than Omicron, is accounting for more than a third of global COVID-19 cases....
Clinical stage pharmaceutical company Cantex Pharmaceuticals has obtained a global licence from Harvard University’s Office of Technology Development The...
The U.S. Food and Drug Administration said on February 23 GlaxoSmithKline and Vir Biotech's COVID-19 antibody treatment should not be used in places with...
Like other viruses, SARS-CoV-2 uses countermeasures to overcome human defenses—countermeasures that can be negated with the help of combination antiviral drugs The post Beating COVID-19 Means...
Sotrovimab and baricitinib target COVID at different stages of its development, and will give doctors greater flexibility in treating omicron patients.